Unexpected failures . . . and successes

Lancet

Volumn 350, Issue SUPPL.3, 1997, Pages

  Mittra, I ^a   Naresh, K N ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; GENE THERAPY; GENETICS; HUMAN; NEOPLASM; REVIEW;

FEMALE; GENE THERAPY; HUMANS; NEOPLASMS;

EID: 0344887601     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)90050-7     Document Type: Article

References (5)

1. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.
2. Kingelhutz AJ. Telomerase activation and cancer. J Mol Med 1997; 75: 45-49.
3. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-55.
4. Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 8840: 265-75.
5. Webb A, Cunningham D, Cotter F, et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997; 349: 1137-41.